The association of single nucleotide polymorphism within vascular endothelial growth factor gene with systemic lupus erythematosus and lupus nephritis

International Journal of Immunogenetics

Volumn 38, Issue 1, 2011, Pages 63-67

  Wongpiyabovorn, J ^a   Hirankarn, N ^a   Ruchusatsawat, K ^b   Yooyongsatit, S ^c   Benjachat, T ^a   Avihingsanon, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 78650802926     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00960.x     Document Type: Article

References (26)

1. Avihingsanon, Y., Phumesin, P., Benjachat, T., Akkasilpa, S., Kittikowit, V., Praditpornsilpa, K. et al. (2006) Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney International, 69, 747.
2. Avihingsanon, Y., Benjachat, T., Tassanarong, A., Sodsai, P., Kittikovit, V. & Hirankarn, N. (2009) Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. Kidney International, 75, 1340.
3. Awata, T., Inoue, K., Kurihara, S., Ohkubo, T., Watanabe, M., Inukai, K., Inoue, I. & Katayama, S. (2002) A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes, 51, 1635.
4. Chow, K.M., Szeto, C.C., Lai, F.M., Poon, P., Wong, T.Y. & Li, P.K. (2006) Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy. Renal Failure, 28, 15.
5. Del Bo, R., Scarlato, M., Ghezzi, S., Maestroni, A., Sjolind, L., Forsblom, C. et al. (2006) VEGF gene variability and type 1 diabetes: evidence for a protective role. Immunogenetics, 58, 107.
6. Feliers, D. (2009) Vascular endothelial growth factor as a prognostic marker of lupus nephritis. Kidney International, 75, 1251.
7. Gunesacar, R., Opelz, G., Erken, E., Pelzl, S., Dohler, B., Ruhenstroth, A. & Susal, C. (2007) VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Human Immunology, 68, 599.
8. Heshmat, N.M. & El-Kerdany, T.H. (2007) Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus. Pediatric Allergy and Immunology, 18, 346.
9. Kamoun, M., Houman, M.H., Hamzaoui, A. & Hamzaoui, K. (2008) Vascular endothelial growth factor gene polymorphisms and serum levels in Behcet's disease. Tissue Antigens, 72, 581.
10. Kang, D.H., Joly, A.H., Oh, S.W., Hugo, C., Kerjaschki, D., Gordon, K.L. et al. (2001) Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. Journal of the American Society of Nephrology, 12, 1434.
11. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L. et al. (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nature Genetics, 34, 383.
12. Navarro, C., Candia-Zuniga, L., Silveira, L.H., Ruiz, V., Gaxiola, M., Avila, M.C. & Amigo, M.C. (2002) Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus, 11, 21.
13. Nieves, B.J., D'Amore, P.A. & Bryan, B.A. (2009) The function of vascular endothelial growth factor. Biofactors, 35, 332.
14. Paydas, S., Balal, M., Tanriverdi, K., Sertdemir, Y. & Baslamisli, F. (2007) The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis. Renal Failure, 29, 779.
15. Reiterova, J., Obeidova, H., Lenicek, M., Stekrova, J., Merta, M., Maixnerova, D., Vitek, L., Viklicky, O. & Tesar, V. (2008) Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. Kidney and Blood Pressure Research, 31, 398.
16. Rueda, B., Perez-Armengol, C., Lopez-Lopez, S., Garcia-Porrua, C., Martin, J. & Gonzalez-Gay, M.A. (2006) Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schonlein purpura. The Journal of Rheumatology, 33, 69.
17. Shen, N. & Tsao, B.P. (2004) Current advances in the human lupus genetics. Current Rheumatology Reports, 6, 391.
18. Shulman, K., Rosen, S., Tognazzi, K., Manseau, E.J. & Brown, L.F. (1996) Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. Journal of the American Society of Nephrology, 7, 661.
19. Stephens, M. & Donnelly, P. (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. American Journal of Human Genetics, 73, 1162.
20. Stevens, A., Soden, J., Brenchley, P.E., Ralph, S. & Ray, D.W. (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Research, 63, 812.
21. Summers, A.M., Coupes, B.M., Brennan, M.F., Ralph, S.A., Short, C.D. & Brenchley, P.E. (2005) VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrology Dialysis Transplantation, 20, 2427.
22. Wakeland, E.K., Liu, K., Graham, R.R. & Behrens, T.W. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity, 15, 397.
23. Watson, C.J., Webb, N.J., Bottomley, M.J. & Brenchley, P.E. (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine, 12, 1232.
24. Wongpiyabovorn, J., Yooyongsatit, S., Ruchusatsawat, K., Avihingsanon, Y. & Hirankarn, N. (2008) Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis. Tissue Antigens, 72, 458.
25. Young, H.S., Summers, A.M., Bhushan, M., Brenchley, P.E. & Griffiths, C.E. (2004) Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. The Journal of Investigative Dermatology, 122, 209.
26. Young, H.S., Summers, A.M., Read, I.R., Fairhurst, D.A., Plant, D.J., Campalani, E. et al. (2006) Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. The Journal of Investigative Dermatology, 126, 453.